Business Description
Oxurion NV
ISIN : BE0974487192
Total Employee Number:
26Compare
Compare
Traded in other countries / regions
OXUR.BelgiumTG40.Germany0G99.UK IPO Date
2007-10-27Description
Oxurion NV is a holding company specializing in acquiring and integrating clinical research services companies (CROs) covering the full clinical research value chain across Europe.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | -3.37 | |||||
Debt-to-Equity | -0.89 | |||||
Debt-to-EBITDA | -3.16 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -42.66 | |||||
Beneish M-Score | 151.03 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -93.3 | |||||
3-Year EBITDA Growth Rate | 96.6 | |||||
3-Year EPS without NRI Growth Rate | 96.5 | |||||
3-Year FCF Growth Rate | 97 | |||||
3-Year Book Growth Rate | 87.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.11 | |||||
Quick Ratio | 0.11 | |||||
Cash Ratio | 0.03 | |||||
Days Sales Outstanding | 551.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1051.5 | |||||
Shareholder Yield % | 114.93 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -590.81 | |||||
Net Margin % | -671.71 | |||||
EBITDA Margin % | -652.43 | |||||
FCF Margin % | -307.21 | |||||
OCF Margin % | -307.21 | |||||
ROA % | -77.13 | |||||
ROIC % | -22.3 | |||||
3-Year ROIIC % | 538.73 | |||||
ROC (Joel Greenblatt) % | -5270 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.33 | |||||
EV-to-EBIT | -3.15 | |||||
EV-to-EBITDA | -3.21 | |||||
EV-to-Revenue | 20.96 | |||||
EV-to-Forward-Revenue | 21.83 | |||||
EV-to-FCF | -6.82 | |||||
Price-to-GF-Value | 0.3 | |||||
Price-to-Median-PS-Value | 0.01 | |||||
Earnings Yield (Greenblatt) % | -31.75 | |||||
FCF Yield % | -404.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Oxurion NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.555 | ||
| EPS (TTM) (€) | -0.281 | ||
| Beta | 1.8317 | ||
| 3-Year Sharpe Ratio | -0.47 | ||
| 3-Year Sortino Ratio | -0.61 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | 0.273 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 0.273 - 0.273 | ||
| Shares Outstanding (Mil) | 140.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Oxurion NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Oxurion NV Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| 0.0001:1 Stock Split | 2024-09-03 | 2.00 (+0.00%) |
Show
Entries
Oxurion NV Frequently Asked Questions
What is Oxurion NV(LTS:0G99)'s stock price today?
The current price of LTS:0G99 is €0.27. The 52 week high of LTS:0G99 is €0.27 and 52 week low is €0.27.
When is next earnings date of Oxurion NV(LTS:0G99)?
The next earnings date of Oxurion NV(LTS:0G99) is .
Does Oxurion NV(LTS:0G99) pay dividends? If so, how much?
Oxurion NV(LTS:0G99) does not pay dividend.
Press Release
Articles on Oxurion NV
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers